For: |
Zhang L, Shen L, Ma JL, Pan KF, Liu WD, Li J, Xiao SD, Lin SR, Classen M, You WC. Eradication of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i24/3915.htm |
Number | Citing Articles |
1 |
Jun Heo, Seong Woo Jeon. Changes in the Eradication Rate of Conventional Triple Therapy forHelicobacter pyloriInfection in Korea. The Korean Journal of Gastroenterology 2014; 63(3): 141 doi: 10.4166/kjg.2014.63.3.141
|
2 |
Duo Chen, Xin-ran Zhang, Yang Zhang, Lian Zhang, Jun-ling Ma, Wei-cheng You, Kai-feng Pan. Hypomethylation of repetitive elements in blood leukocyte DNA and risk of gastric lesions in a Chinese population. Cancer Epidemiology 2016; 41: 122 doi: 10.1016/j.canep.2016.02.004
|
3 |
Zhuoqi Liu, Jing Shen, Lian Zhang, Lin Shen, Qiang Li, Baozhen Zhang, Jing Zhou, Liankun Gu, Guoshuang Feng, Junling Ma, Wei-Cheng You, Dajun Deng. Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history. BMC Microbiology 2008; 8(1) doi: 10.1186/1471-2180-8-81
|
4 |
Wen-Qing Li, Kai-Feng Pan, Yang Zhang, Cai-Xuan Dong, Lian Zhang, Jun-Ling Ma, Tong Zhou, Ji-You Li, Wei-Cheng You. RUNX3 methylation and expression associated with advanced precancerous gastric lesions in a Chinese population. Carcinogenesis 2011; 32(3): 406 doi: 10.1093/carcin/bgq259
|
5 |
Ming-Cheh Chen, Wei-Yi Lei, Jen-Shung Lin, Chih-Hsun Yi, Deng-Chyang Wu, Chi-Tan Hu. Levofloxacin-Amoxicillin/Clavulanate-Rabeprazole versus a Standard Seven-Day Triple Therapy for Eradication ofHelicobacter pyloriInfection. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/158520
|
6 |
David Y Graham, Hong Lu, Yoshio Yamaoka. Therapy for Helicobacter pylori Infection Can be Improved. Drugs 2008; 68(6): 725 doi: 10.2165/00003495-200868060-00001
|
7 |
Cai‐Xuan Dong, Da‐Jun Deng, Kai‐Feng Pan, Lian Zhang, Yang Zhang, Jing Zhou, Wei‐Cheng You. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: A population‐based study. International Journal of Cancer 2009; 124(2): 434 doi: 10.1002/ijc.23891
|
8 |
Qi Chen, Xiaohua Long, Yingjie Ji, Xiao Liang, Dongping Li, Hong Gao, Beili Xu, Ming Liu, Ying Chen, Yunwei Sun, Yan Zhao, Gang Xu, Yanyan Song, Lou Yu, Wei Zhang, Wenzhong Liu, David Y. Graham, Hong Lu. Randomised controlled trial: susceptibility‐guided therapy versus empiric bismuth quadruple therapy for first‐line Helicobacter pylori treatment. Alimentary Pharmacology & Therapeutics 2019; 49(11): 1385 doi: 10.1111/apt.15273
|
9 |
Ning Zhou, Wei-xing Chen, Wei Zhang, Lan Li, Xi Jin, You-ming Li. Is short-term therapy really sufficient to eradicate Helicobacter pylori infection?. Journal of Zhejiang University SCIENCE B 2010; 11(9): 690 doi: 10.1631/jzus.B1000008
|
10 |
Ben Wang, Zhi-Fa Lv, You-Hua Wang, Hui Wang, Xiao-Qun Liu, Yong Xie, Xiao-Jiang Zhou. Standard triple therapy for <italic>Helicobacter pylori</italic> infection in China: A meta-analysis. World Journal of Gastroenterology 2014; 20(40): 14973-14985 doi: 10.3748/wjg.v20.i40.14973
|
11 |
Junling Ma, Weidong Liu, Lian Zhang, Kaifeng Pan, Hongjun Zhao, Tong Zhou, Sidney Winawer, Ann Zauber, Meinhard Classen, Weicheng You. A placebo-controlled trial of 10-day bismuth-based quadruple therapy to eradicate Helicobacter pylori infection; a pilot study for the large Linqu County trial. European Journal of Gastroenterology & Hepatology 2010; 22(5): 597 doi: 10.1097/MEG.0b013e3283337146
|
12 |
Kai-feng Pan, Lian Zhang, Markus Gerhard, Jun-ling Ma, Wei-dong Liu, Kurt Ulm, Jian-xi Wang, Lei Zhang, Yang Zhang, Monther Bajbouj, Lan-fu Zhang, Ming Li, Michael Vieth, Rui-yong Liu, Michael Quante, Le-hua Wang, Stepan Suchanek, Tong Zhou, Wei-xiang Guan, Roland Schmid, Meinhard Classen, Wei-cheng You. A large randomised controlled intervention trial to prevent gastric cancer by eradication ofHelicobacter pyloriin Linqu County, China: baseline results and factors affecting the eradication. Gut 2016; 65(1): 9 doi: 10.1136/gutjnl-2015-309197
|
13 |
David Y. Graham, Hong Lu, Yoshio Yamaoka. A Report Card to Grade Helicobacter pylori Therapy. Helicobacter 2007; 12(4): 275 doi: 10.1111/j.1523-5378.2007.00518.x
|